CAS 108852-90-0: Nemorubicin
Description:Nemorubicin is an anthracycline antibiotic that is primarily used in cancer treatment, particularly for its antitumor properties. It is derived from the natural product daunorubicin and is known for its ability to intercalate DNA, thereby inhibiting DNA and RNA synthesis, which ultimately leads to cell death. The chemical structure of nemorubicin includes a tetracyclic ring system characteristic of anthracyclines, which contributes to its biological activity. It exhibits a broad spectrum of activity against various types of cancer, including leukemia and solid tumors. The compound is also noted for its potential cardiotoxicity, a common side effect associated with anthracycline derivatives, necessitating careful monitoring during treatment. Additionally, nemorubicin has been studied for its pharmacokinetics, which involve its absorption, distribution, metabolism, and excretion in the body. Research continues to explore its efficacy and safety profile, as well as potential combinations with other therapeutic agents to enhance its anticancer effects while minimizing adverse reactions.
Formula:C32H37NO13
InChI:InChI=1S/C32H37NO13/c1-14-27(36)17(33-7-8-44-22(12-33)43-3)9-21(45-14)46-19-11-32(41,20(35)13-34)10-16-24(19)31(40)26-25(29(16)38)28(37)15-5-4-6-18(42-2)23(15)30(26)39/h4-6,14,17,19,21-22,27,34,36,38,40-41H,7-13H2,1-3H3/t14-,17-,19-,21-,22-,27+,32-/m0/s1
InChI key:InChIKey=CTMCWCONSULRHO-UHQPFXKFSA-N
SMILES:O=C1C=2C=CC=C(OC)C2C(=O)C=3C(O)=C4C(=C(O)C13)CC(O)(C(=O)CO)CC4OC5OC(C)C(O)C(N6CCOC(OC)C6)C5
- Synonyms:
- (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,3,6-trideoxy-3-[(2S)-2-methoxymorpholin-4-yl]-alpha-L-lyxo-hexopyranoside
- (1S,3S)-3-Glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl 2,3,6-trideoxy-3-[(S)-2-methoxymorpholino]-α-<span class="text-smallcaps">L</span>-lyxo-hexopyranoside
- (8S,10S)-7,8,9,10-Tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-[(2S)-2-methoxy-4-morpholinyl]-α-<span class="text-smallcaps">L</span>-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione
- 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-[(2S)-2-methoxy-4-morpholinyl]-α-<span class="text-smallcaps">L</span>-lyxo-hexopyranosyl]oxy]-, (8S,10S)-
- 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-2,3,6-trideoxy-3-(2S)-2-methoxy-4-morpholinyl-.alpha.-L-lyxo-hexopyranosyloxy-, (8S,10S)-
- 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-(2-methoxy-4-morpholinyl)-α-<span class="text-smallcaps">L</span>-lyxo-hexopyranosyl]oxy]-, [8S-[8α,10α(R*)]]-
- 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-[(2S)-2-methoxy-4-morpholinyl]-α-<span class="text-smallcaps">L</span>-lyxo-hexopyranosyl]oxy]-, (8S,10S)-
- DMM Dox
- Fce 23762
- Methoxy-Morpholynil-Doxorubicin
- See more synonyms
- Methoxymorpholinyldoxorubicin
- Mmrdx
- Pnu 152243
- (8S,10S)-7,8,9,10-Tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-[(2S)-2-methoxy-4-morpholinyl]-α-L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione
- 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-[(2S)-2-methoxy-4-morpholinyl]-α-L-lyxo-hexopyranosyl]oxy]-, (8S,10S)-
- 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-[(2S)-2-methoxy-4-morpholinyl]-α-L-lyxo-hexopyranosyl]oxy]-, (8S,10S)-
- 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-(2-methoxy-4-morpholinyl)-α-L-lyxo-hexopyranosyl]oxy]-, [8S-[8α,10α(R*)]]-
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | Nemorubicin REF: IN-DA008TIJCAS: 108852-90-0 | 98% | To inquire | Tue 22 Apr 25 |
![]() | Nemorubicin REF: 54-BUP01828CAS: 108852-90-0 | 97.78% | 646.00 €~1,230.00 € | Mon 21 Apr 25 |
![]() | Nemorubicin REF: TM-T4469CAS: 108852-90-0 | 97.79% | 56.00 €~908.00 € | Tue 29 Apr 25 |
![]() | Nemorubicin REF: 3D-BN180615CAS: 108852-90-0 | Min. 98 Area-% | 649.00 €~4,030.00 € | Fri 02 May 25 |

Nemorubicin
Ref: IN-DA008TIJ
50mg | 253.00 € | ||
100mg | 570.00 € |

Ref: 54-BUP01828
25mg | 646.00 € | ||
50mg | 938.00 € | ||
100mg | 1,230.00 € |

Nemorubicin
Ref: TM-T4469
1mg | 56.00 € | ||
5mg | 119.00 € | ||
10mg | 187.00 € | ||
25mg | 432.00 € | ||
50mg | 638.00 € | ||
100mg | 908.00 € |

Nemorubicin
Ref: 3D-BN180615
1mg | 649.00 € | ||
2mg | 1,054.00 € | ||
5mg | 1,324.00 € | ||
10mg | 2,096.00 € | ||
25mg | 4,030.00 € |